Bearish Moving normal Cross by Isis Pharmaceuticals (ISIS) Financial News system Online The company currently has various compounds in clinical trials for type A variety of diseases specified as Crohn's disease, disease of the skin , asthma, and cancer. Isis' broad medical natural science and biology research programs support efforts in both antisense and small ... and more » Link To Article
No comments:
Post a Comment